dm+d

96086002

Articles

Safety in Lactation: Anti-infective eye preparations

30 October 2020Anti-infective preparations for ophthalmic use have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. Systemic absorption from eye drops…

Safety in Lactation: Quinolones

21 October 2020Quinolones are generally accepted for use during breastfeeding, with caution. There have been concerns about adverse effects on infants’ developing joints, although this has only…

Raising the profile of medicines safety: Changing practice and sharing learning from medication incidents

22 August 2019The Patient Safety Alert: Improving medication error incident and reporting1,2  raised the profile of medicines safety in our Trust (CDDFT). Our evolving programme, focussing on…
Search Articles

Medicine Compliance Aid Stability

TarividSanofi

Sanofi
Tarivid
Tablets 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from moisture in an airtight container.
19 June 2015

Lactation Safety Information

Oral / Intravenous

Oral / Intravenous
Ciprofloxacin
Limited published evidence of safety
Small amounts in breast milk
Avoid breastfeeding for 4–6 hours after the dose if possible
17 September 2020

For ophthalmic use

For ophthalmic use
Yes
17 September 2020